Cargando…
The ATP sensitive potassium channel (K(ATP)) is a novel target for migraine drug development
Migraine is one of the leading causes of disability worldwide, affecting work and social life. It has been estimated that sales of migraine medicines will reach 12.9 billion USD in 2027. To reduce social impact, migraine treatments must improve, and the ATP-sensitive potassium (K(ATP)) channel is a...
Autores principales: | Clement, Amalie, Christensen, Sarah Louise, Jansen-Olesen, Inger, Olesen, Jes, Guo, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338883/ https://www.ncbi.nlm.nih.gov/pubmed/37456521 http://dx.doi.org/10.3389/fnmol.2023.1182515 |
Ejemplares similares
-
ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential
por: Clement, Amalie, et al.
Publicado: (2022) -
Pharmacological Profiling of K(ATP) Channel Modulators: An Outlook for New Treatment Opportunities for Migraine
por: Dyhring, Tino, et al.
Publicado: (2023) -
The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017) -
The dynamic interplay of PIP(2) and ATP in the regulation of the K(ATP) channel
por: Pipatpolkai, Tanadet, et al.
Publicado: (2022) -
ATP-sensitive potassium channel (K(ATP )channel) expression in the normal canine pancreas and in canine insulinomas
por: Donley, Vicky R, et al.
Publicado: (2005)